💰NIH Closed Meeting Notice for Grant Applications in Health Research
The Department of Health and Human Services announces a closed meeting for the National Institute of Arthritis and Musculoskeletal and Skin Diseases. The meeting will focus on reviewing grant applications, which may involve discussions on confidential information and trade secrets. The event is vital for stakeholders in the health research domain, enabling insights into funding opportunities and strategic collaborations.
Learn More🧬NIH Notice of Closed Meeting on Aging Research Grants
The National Institute on Aging announces a closed meeting to evaluate grant applications concerning Alzheimer's Disease and Related Dementias (AD/ADRD). The meeting, conducted virtually, is confidential to protect sensitive information related to the applications. Attendees can connect with research officers to discuss potential grants.
Learn More🧪NIH Notice of Closed Meeting for Grant Application Review
The National Institute of Allergy and Infectious Diseases has announced a closed meeting to review and evaluate grant applications. This meeting is part of ongoing federal efforts to advance research in allergy, immunology, and infectious diseases, and will address confidential aspects related to the applications under consideration.
Learn More🔬Notice of Closed NIH Meeting on Grant Applications Review
The Department of Health and Human Services announces a closed meeting for the National Institute of Allergy and Infectious Diseases Special Emphasis Panel. The meeting will evaluate grant applications related to allergy, immunology, and infectious diseases, focusing on the confidentiality of trade secrets and personal information concerning applicants.
Learn More🏥National Cancer Institute Notice on Grant Review Meetings
The National Cancer Institute announces closed meetings to review grant applications related to diet, lipid metabolism, and cancer. These meetings are in compliance with federal law and focus on evaluating grant applications, likely affecting confidential trade secrets and personal privacy issues within the field.
Learn More💰National Cancer Institute Grant Opportunities Announcement – April 2025
The Department of Health and Human Services announces a closed meeting by the National Cancer Institute to review grant applications related to cancer research. The notice emphasizes the confidentiality of discussions and outlines meeting details, including date, time, and location, highlighting the importance of privacy in grant evaluations.
Learn More💼Notice of NIH Grant Review Meeting by Heart, Lung, and Blood Institute
The National Heart, Lung, and Blood Institute announces a closed meeting to review grant applications. The meeting, scheduled for April 22, 2025, will evaluate confidential trade secrets and personal information, ensuring privacy during discussions on significant health research funding. Contact details are provided for further inquiries.
Learn More🚀NASA Notice
NASA hereby gives notice of its intent to grant an exclusive, co-exclusive or partially exclusive patent license to practice the inventions described and claimed in the patents and/or patent applications listed in SUPPLEMENTARY INFORMATION below.
Learn More💰NIH Meeting Notice
The Department of Health and Human Services announces closed meetings of the National Institutes of Health's Center for Scientific Review to evaluate grant applications related to addiction, cancer immunology, and Down syndrome research. The meetings emphasize confidentiality, focusing on the protection of trade secrets and personal information while providing insights into future funding opportunities in healthcare and scientific research.
Learn More💰NIH Closed Meetings on Grant Applications
The National Institutes of Health announces a series of closed meetings to evaluate grant applications across various scientific review committees. These sessions are crucial for organizations seeking financial support for research and development projects in healthcare, reflecting the agency’s focus on advancing scientific inquiry and innovation.
Learn More